RBC Capital has upgraded Colgate-Palmolive Co (CL) to Outperform from Sector Perform, reflecting a more optimistic view on the company's future prospects. This change may indicate improved fundamentals, better-than-expected business performance, or increased confidence in its strategic direction.
Colgate-Palmolive, headquartered in New York City, engages in the manufacturing and distribution of consumer products, focusing on oral care, personal care, home care, and pet nutrition. The company operates under numerous brands, including Colgate, Palmolive, and Hill's Science Diet, and employs approximately 34,000 full-time staff.
As of December 4, 2025, the company's market capitalisation stands at $63.1 billion, with a P/E ratio of 21.70 and an EPS of 3.57. The current stock price is $78.39, and the dividend yield is notably high at 266.0%. Upcoming earnings reports are scheduled for July 30, 2026, with an EPS estimate of $0.99 and revenue expected to reach $5.4 billion.
Analyst ratings and price targets serve as professional assessments based on research and financial models. While these insights can provide useful perspective, they are based on assumptions that may not materialise as anticipated. Investors should consider a range of factors, including company fundamentals, competitive positioning, and industry trends, when making decisions. Analyst opinions should be one of many inputs rather than the sole basis for investment choices.
The upgrade by RBC Capital underscores the evolving sentiment surrounding Colgate-Palmolive, which has seen a mixture of ratings in recent months. As of December 1, 2025, the consensus among analysts is a Buy, with 6 Strong Buy, 12 Buy, 10 Hold, 1 Sell, and 1 Strong Sell ratings issued. Analyst actions can change over time as new information becomes available, highlighting the importance of ongoing research in investment decisions.